Author's posts
The deadly consequences of a shortage: The Pluvicto crisis leaves metastatic prostate cancer patients in limbo
You’ve recently been diagnosed with metastatic cancer. You started the recommended first-line therapy, but it isn’t cutting it. There is another available treatment, but your hopes are crushed upon learning that you will have to wait at lea…
